A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

NCT03817424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus
Sjogren's Syndrome
Systemic Sclerosis
Polymyositis
Dermatomyositis

Interventions

DRUG: VIB7734
DRUG: Placebo

Sponsor

Amgen